PD-protec™ is being developed to improve the survival of patients undergoing peritoneal dialysis (PD). A Phase I/II clinical trial of PD-Protec™ is ongoing.

PD is an effective treatment option for patients suffering from end-stage renal disease, or kidney failure.

Current PD fluids, however, damage the patients’ peritoneum over time, limiting the time patients can survive on this treatment.

PD-protec™ is designed to protect peritoneal cells from the degeneration caused by current PD fluids.